Capforce Inc 's ability to collect accounts receivable sequentially worsen to 5.56, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Capforce Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 66 days, from 26 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Capforce Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Capforce Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CFOR Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	1144.35 %	644.06 %	750.27 %	16472.43 %	15800.16 %
Y / Y Revenue Change	1150 %	-	424 %	-	14185.71 %
Receivable Turnover Ratio (TTM)	5.56	14.07	14.44	4.42	8.72
CFOR's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	66	26	25	83	42
Seq. Receivable Change	19710.73 %	1.98 %	-93.85 %	0.12 %	11745.84 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CFOR Company Profile • Back to CFOR Efficiency Comparisons • Compare CFOR Receivables Turnover Ratio to its Competitors

Financial Statements
Capforce Inc 's Accounts Receivable	$ 50 Millions	Visit CFOR's Balance sheet
Capforce Inc 's Sales TTM	$ 76 Millions	Visit CFOR's Income Statement
Sources of CFOR's Revenues		Visit CFOR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CFOR's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CFOR's Growth Rates	CFOR's Roa	CFOR's Inventory Turnover Ratio	CFOR's Dividend Comparisons
CFOR's Profitability Ratios	CFOR's Roi	CFOR's Asset Turnover Ratio	CFOR's Dividend Growth
CFOR's Valuation Ratios	CFOR's Roe	CFOR's Financial Strength Ratios	CFOR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Retractable Technologies Inc	4.14	$ 33.488 Millions	$ 8.087 Millions
Apyx Medical Corp	4.14	$ 58.105 Millions	$ 14.035 Millions
Regenxbio Inc	4.13	$ 174.482 Millions	$ 42.238 Millions
Revvity Inc	4.12	$ 2,911.811 Millions	$ 706.371 Millions
Pro dex Inc	4.12	$ 77.548 Millions	$ 18.836 Millions
Stoke Therapeutics Inc	4.12	$ 27.588 Millions	$ 6.704 Millions
Medinotec Inc	4.08	$ 10.247 Millions	$ 2.513 Millions
Amgen Inc	4.07	$ 38,095.000 Millions	$ 9,356.250 Millions
Nexalin Technology Inc	4.07	$ 0.217 Millions	$ 0.053 Millions
Outset Medical Inc	4.06	$ 117.551 Millions	$ 28.959 Millions
Butterfly Network Inc	4.05	$ 112.360 Millions	$ 27.732 Millions
Ironwood Pharmaceuticals inc	4.04	$ 389.316 Millions	$ 96.422 Millions
Pelthos Therapeutics Inc	4.03	$ 43.304 Millions	$ 10.757 Millions
Upstream Bio Inc	4.00	$ 3.158 Millions	$ 0.789 Millions
Skinvisible Inc	4.00	$ 0.020 Millions	$ 0.005 Millions
Xencor Inc	3.99	$ 104.973 Millions	$ 26.335 Millions
Bridgebio Pharma Inc	3.99	$ 713.069 Millions	$ 178.918 Millions
Teva Pharmaceutical Industries Limited	3.92	$ 14,105.000 Millions	$ 3,601.250 Millions
Verrica Pharmaceuticals Inc	3.92	$ 30.321 Millions	$ 7.743 Millions
Teleflex Incorporated	3.90	$ 1,628.534 Millions	$ 417.093 Millions
Iovance Biotherapeutics inc	3.90	$ 324.969 Millions	$ 83.272 Millions
Vanda Pharmaceuticals Inc	3.89	$ 215.721 Millions	$ 55.423 Millions
Immunitybio inc	3.87	$ 165.792 Millions	$ 42.832 Millions
Insight Molecular Diagnostics Inc	3.85	$ 1.670 Millions	$ 0.434 Millions
Tonix Pharmaceuticals Holding Corp	3.83	$ 29.102 Millions	$ 7.594 Millions
Urogen Pharma Ltd	3.82	$ 188.317 Millions	$ 49.239 Millions
Akebia Therapeutics Inc	3.82	$ 219.060 Millions	$ 57.324 Millions
Eyepoint Inc	3.79	$ 2.788 Millions	$ 0.735 Millions
Alpha Cognition Inc.	3.78	$ 15.261 Millions	$ 4.034 Millions
Biomarin Pharmaceutical Inc	3.72	$ 3,406.614 Millions	$ 915.860 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.